Nemaura Announces First SugarBEAT Device Shipments

Nemaura Medical (NASDAQ:NMRD) has announced the first shipments of its SugarBEAT devices to diabetic and prediabetic patients in the United...

Nemaura Receives CE Mark Approval of SugarBEAT

Nemaura Medical (NASDAQ:NMRD) has announced it has received CE Mark approval for SugarBEAT, a non-invasive device for diabetics and pre-diabetics....

Dexcom G6 CGM System Receives CE Mark

Dexcom (NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM), announced today that the company has received CE Mark for its Dexcom...